MedPath

metolazone

Metolazone Tablets, USP

Approved
Approval ID

fae89daa-9103-45d8-9966-cd998f258625

Product Type

HUMAN PRESCRIPTION DRUG LABEL

Effective Date

Sep 12, 2018

Manufacturers
FDA

Aphena Pharma Solutions - Tennessee, LLC

DUNS: 128385585

Products 1

Detailed information about drug products covered under this FDA approval, including NDC codes, dosage forms, ingredients, and administration routes.

metolazone

PRODUCT DETAILS

NDC Product Code71610-142
Application NumberNDA017386
Marketing CategoryC73605
Route of AdministrationORAL
Effective DateSeptember 10, 2018
Generic Namemetolazone

INGREDIENTS (4)

MAGNESIUM STEARATEInactive
Code: 70097M6I30
Classification: IACT
METOLAZONEActive
Quantity: 2.5 mg in 1 1
Code: TZ7V40X7VX
Classification: ACTIB
CELLULOSE, MICROCRYSTALLINEInactive
Code: OP1R32D61U
Classification: IACT
D&C RED NO. 33Inactive
Code: 9DBA0SBB0L
Classification: IACT
© Copyright 2025. All Rights Reserved by MedPath
metolazone - FDA Approval | MedPath